While this hypothesis has not been developed to the same extent as the amyloid, tau and mitochondrial hypotheses, the idea is grounded in the fact that anti-neuronal antibodies have been found in the sera of AD patients. The gene discussed is MAPT; the disease is Alzheimer disease.